JP2016522178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016522178A5 JP2016522178A5 JP2016509119A JP2016509119A JP2016522178A5 JP 2016522178 A5 JP2016522178 A5 JP 2016522178A5 JP 2016509119 A JP2016509119 A JP 2016509119A JP 2016509119 A JP2016509119 A JP 2016509119A JP 2016522178 A5 JP2016522178 A5 JP 2016522178A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- angiotensin
- peptide
- muscular dystrophy
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361813929P | 2013-04-19 | 2013-04-19 | |
| US61/813,929 | 2013-04-19 | ||
| US201361818307P | 2013-05-01 | 2013-05-01 | |
| US61/818,307 | 2013-05-01 | ||
| PCT/US2014/034615 WO2014189634A1 (en) | 2013-04-19 | 2014-04-18 | Angiotensins in muscular dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016522178A JP2016522178A (ja) | 2016-07-28 |
| JP2016522178A5 true JP2016522178A5 (https=) | 2017-05-25 |
Family
ID=51933952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016509119A Pending JP2016522178A (ja) | 2013-04-19 | 2014-04-18 | 筋ジストロフィーにおけるアンジオテンシン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160074464A1 (https=) |
| EP (1) | EP2986341A4 (https=) |
| JP (1) | JP2016522178A (https=) |
| KR (1) | KR20160026855A (https=) |
| CN (1) | CN105636645A (https=) |
| AU (1) | AU2014269028A1 (https=) |
| BR (1) | BR112015026286A2 (https=) |
| CA (1) | CA2909002A1 (https=) |
| MX (1) | MX2015014668A (https=) |
| RU (1) | RU2015141336A (https=) |
| WO (1) | WO2014189634A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3169405T3 (da) | 2014-07-17 | 2024-09-23 | Univ Southern California | Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme |
| US10973869B2 (en) | 2017-05-17 | 2021-04-13 | Constant Therapeutics Llc | Methods of treating cardiomyopathy associated with genetic disorders |
| ES2958954T3 (es) | 2018-11-06 | 2024-02-16 | Edgewise Therapeutics Inc | Compuestos de piridazinona y usos de los mismos |
| WO2020097258A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EP3877052B1 (en) * | 2018-11-06 | 2023-08-16 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| CN118680926B (zh) * | 2024-07-30 | 2024-12-20 | 北京市糖尿病研究所(北京市糖尿病防治办公室) | Mas受体激动剂在制备预防或治疗多囊卵巢综合征的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU78601A (sh) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| EP2124991B1 (en) * | 2007-01-26 | 2013-11-27 | Universidade Federal De Minas Gerais - UFMG | Pharmaceutical compositions and methods for treating erectile dysfunction |
| EP2163259B1 (en) * | 2008-09-12 | 2012-06-13 | Charité-Universitätsmedizin Berlin (Charité) | Use of an Ang-(1-7) receptor agonist in acute lung injury |
| WO2013063277A1 (en) * | 2011-10-25 | 2013-05-02 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| BR132012028005E2 (pt) * | 2012-10-31 | 2014-11-18 | Univ Minas Gerais | Composições farmacêuticas contendo um agonista do receptor mas para o tratamento de doenças degenerativas musculares. |
-
2014
- 2014-04-18 WO PCT/US2014/034615 patent/WO2014189634A1/en not_active Ceased
- 2014-04-18 US US14/785,538 patent/US20160074464A1/en not_active Abandoned
- 2014-04-18 BR BR112015026286A patent/BR112015026286A2/pt not_active Application Discontinuation
- 2014-04-18 CN CN201480034275.5A patent/CN105636645A/zh active Pending
- 2014-04-18 JP JP2016509119A patent/JP2016522178A/ja active Pending
- 2014-04-18 CA CA2909002A patent/CA2909002A1/en not_active Abandoned
- 2014-04-18 AU AU2014269028A patent/AU2014269028A1/en not_active Abandoned
- 2014-04-18 EP EP14800597.8A patent/EP2986341A4/en not_active Withdrawn
- 2014-04-18 RU RU2015141336A patent/RU2015141336A/ru not_active Application Discontinuation
- 2014-04-18 KR KR1020157032700A patent/KR20160026855A/ko not_active Withdrawn
- 2014-04-18 MX MX2015014668A patent/MX2015014668A/es unknown
-
2017
- 2017-09-05 US US15/695,731 patent/US20180221433A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016522178A5 (https=) | ||
| JP2017500018A5 (https=) | ||
| JP2015517489A5 (https=) | ||
| FI3442602T3 (fi) | Mikrodystrofiinin anto adeno-assioituneella virusvektorilla lihasdystrofian hoitamiseksi | |
| JP2014527040A5 (https=) | ||
| JP2016529229A5 (https=) | ||
| JP5255456B2 (ja) | ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法 | |
| RU2015141336A (ru) | Ангиотензины при мышечной дистрофии | |
| JP2011507891A5 (https=) | ||
| JP2019511222A5 (https=) | ||
| JP2019507781A5 (https=) | ||
| JP2006522830A5 (https=) | ||
| JP2017535547A5 (https=) | ||
| JP2012512641A5 (https=) | ||
| JP2016506914A5 (https=) | ||
| JP2004534850A5 (https=) | ||
| PH12015502141B1 (en) | Substituted xanthines and methods of use thereof | |
| FI3700529T3 (fi) | Uusi aktiivisten aineiden yhdistelmä etenevien fibrotisoivien interstitiaalisten keuhkosairauksien (pf-ild) hoitoon | |
| JP2017511377A5 (https=) | ||
| JP2016506386A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| JP2015164424A5 (https=) | ||
| JP2020531520A5 (https=) | ||
| JP2019529541A5 (https=) | ||
| JP2017160178A5 (https=) |